| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |